eBay
EBAY
Halozyme Therapeutics
HALO
Constellation Brands
STZ
4
Workday
WDAY
5
Lantheus
LNTH
US Stock MarketDetailed Quotes
VCYT Veracyte
- 30.500
- -0.880-2.80%
Close Apr 30 16:00 ET
- 30.500
- 0.0000.00%
Post 16:22 ET
2.39BMarket Cap98.39P/E (TTM)
31.375High30.160Low1.07MVolume30.660Open31.380Pre Close32.72MTurnover1.37%Turnover Ratio98.39P/E (Static)78.31MShares47.31652wk High2.03P/B2.38BFloat Cap19.73052wk Low--Dividend TTM77.93MShs Float86.030Historical High--Div YieldTTM3.87%Amplitude4.210Historical Low30.544Avg Price1Lot Size
Veracyte Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 69.82%75.1M | 57.69%24.52M | 111.44%29.96M | 77.40%29.58M | -312.80%-8.97M | 486.89%44.22M | 59.61%15.55M | 101.69%14.17M | 4,692.56%16.67M | 75.52%-2.17M |
| Net income from continuing operations | 132.44%24.14M | 118.07%5.11M | 151.17%15.16M | 168.25%5.73M | 76.96%-1.86M | -103.51%-74.4M | -636.03%-28.29M | -239.54%-29.62M | 11.85%-8.4M | 44.05%-8.09M |
| Operating gains losses | 380.24%2.31M | 283.31%2.97M | -296.36%-1.62M | 312.50%297K | 747.57%667K | -213.32%-825K | -78.39%-1.62M | -10.34%824K | -87.69%72K | -178.63%-103K |
| Depreciation and amortization | -13.72%23.46M | -1.31%6.25M | -19.73%5.88M | -16.34%5.74M | -16.19%5.59M | 4.86%27.19M | -3.36%6.34M | 15.80%7.32M | 5.65%6.86M | 1.74%6.67M |
| Deferred tax | 93.93%-233K | 91.89%-243K | 98.66%-13K | 14.40%143K | ---120K | -2,986.47%-3.84M | -843.42%-3M | -536.84%-968K | 208.70%125K | --0 |
| Other non cash items | 681.39%7.12M | 96.68%2.25M | 142.97%1.72M | 65.10%2.01M | 173.68%1.14M | -133.70%-1.23M | 7.31%1.15M | -559.59%-4M | 18.42%1.22M | -37.70%418K |
| Change In working capital | -412.11%-21.32M | -394.32%-4.2M | 94.13%-91K | -9.62%5.8M | -118.25%-22.83M | 74.59%-4.16M | 458.54%1.43M | -407.54%-1.55M | 179.51%6.42M | -24.37%-10.46M |
| -Change in receivables | -264.78%-6.41M | 360.94%1.99M | -40.93%1.69M | -217.34%-3.63M | -396.08%-6.46M | 186.47%3.89M | -448.92%-763K | 301.48%2.86M | 383.72%3.09M | 63.58%-1.3M |
| -Change in inventory | -246.58%-5.87M | -2,824.14%-1.7M | 79.43%-909K | -155.76%-963K | -318.29%-2.3M | 43.74%-1.69M | 65.88%-58K | -643.42%-4.42M | 170.40%1.73M | 187.84%1.06M |
| -Change in prepaid assets | -182.97%-1.3M | -229.02%-1.45M | 144.96%2.33M | 3.93%555K | 10.64%-2.74M | -132.95%-458K | -20.85%1.12M | -47.26%952K | 72.82%534K | -43.24%-3.06M |
| -Change in payables and accrued expense | 5.68%-764K | -170.94%-1.71M | -348.35%-1.22M | 359.09%12.7M | -84.57%-10.54M | 78.50%-810K | -6.89%2.41M | -185.31%-273K | 152.00%2.77M | -322.89%-5.71M |
| -Change in other current assets | -107.92%-1.58M | 177.91%134K | -207.58%-497K | -164.27%-1.47M | 152.75%259K | 75.14%-758K | 94.64%-172K | 472.58%462K | -233.53%-557K | -208.87%-491K |
| -Change in other current liabilities | -24.87%-5.41M | -33.76%-1.48M | -30.78%-1.48M | -22.09%-1.39M | -10.84%-1.05M | -25.58%-4.33M | -25.85%-1.11M | -27.42%-1.13M | -5.36%-1.14M | -59.13%-950K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 69.82%75.1M | 57.69%24.52M | 111.44%29.96M | 77.40%29.58M | -312.80%-8.97M | 486.89%44.22M | 59.61%15.55M | 101.69%14.17M | 4,692.56%16.67M | 75.52%-2.17M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -472.39%-56.28M | -2,068.24%-54.14M | 19.99%-2.24M | 24.50%-2.77M | -88.05%2.88M | 151.42%15.11M | 90.55%-2.5M | -131.82%-2.8M | 60.58%-3.67M | 1,081.66%24.08M |
| Net PPE purchase and sale | -13.31%-11.29M | -65.84%-4.14M | 19.99%-2.24M | 24.50%-2.77M | -114.90%-2.13M | -16.52%-9.96M | -33.39%-2.5M | -63.48%-2.8M | -46.18%-3.67M | 59.52%-993K |
| Net business purchase and sale | --5.01M | --0 | --0 | --0 | --5.01M | --0 | --0 | --0 | --0 | --0 |
| Net investment purchase and sale | -299.42%-50M | ---50M | --0 | --0 | --0 | 220.32%25.07M | --0 | --0 | --0 | --25.07M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -472.39%-56.28M | -2,068.24%-54.14M | 19.99%-2.24M | 24.50%-2.77M | -88.05%2.88M | 151.42%15.11M | 90.55%-2.5M | -131.82%-2.8M | 60.58%-3.67M | 1,081.66%24.08M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 72.86%4.9M | -799.22%-4.51M | 9,253.64%10.29M | -102.77%-11K | -151.28%-864K | -18.80%2.84M | 593.55%645K | -92.60%110K | 629.33%397K | -15.33%1.69M |
| Net issuance payments of debt | --0 | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Proceeds from stock option exercised by employees | 108.74%19.99M | 84.20%3.26M | 387.83%12.47M | 0.31%1.29M | -25.09%2.97M | 20.60%9.58M | -1.99%1.77M | 13.25%2.56M | 278.82%1.29M | 12.02%3.96M |
| Net other financing activities | -123.84%-15.09M | -589.80%-7.77M | 10.87%-2.18M | -46.24%-1.3M | -68.29%-3.83M | -112.85%-6.74M | -113.45%-1.13M | -216.02%-2.45M | -113.16%-891K | -57.36%-2.28M |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 72.86%4.9M | -799.22%-4.51M | 9,253.64%10.29M | -102.77%-11K | -151.28%-864K | -18.80%2.84M | 593.55%645K | -92.60%110K | 629.33%397K | -15.33%1.69M |
| Net cash flow | ||||||||||
| Beginning cash position | 40.22%217.33M | 35.32%275.16M | 23.42%237M | 17.71%210.27M | 40.22%217.33M | -10.89%155M | 19.00%203.33M | 24.54%192.03M | 8.68%178.64M | -10.89%155M |
| Current changes in cash | -61.84%23.73M | -349.10%-34.13M | 231.13%38.01M | 99.97%26.79M | -129.47%-6.95M | 438.66%62.17M | 182.55%13.7M | -33.72%11.48M | 237.50%13.4M | 352.74%23.59M |
| Effect of exchange rate changes | -360.12%-424K | -235.02%-401K | 182.49%146K | -771.43%-61K | -316.00%-108K | 127.53%163K | -59.43%297K | 72.94%-177K | 98.35%-7K | 120.24%50K |
| End cash Position | 10.72%240.63M | 10.72%240.63M | 35.32%275.16M | 23.42%237M | 17.71%210.27M | 40.22%217.33M | 40.22%217.33M | 19.00%203.33M | 24.54%192.03M | 8.68%178.64M |
| Free cash flow | 86.24%63.81M | 56.13%20.38M | 143.83%27.72M | 106.16%26.81M | -250.71%-11.1M | 3,478.80%34.26M | 65.84%13.06M | 114.02%11.37M | 552.56%13M | 72.05%-3.17M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | -- | -- | -- | -- | -- |
Market Insights
Discussing
Trade war escalates: What’s next for Chinese stocks?
🎙️Discussion 1. China-EU EV negotiations kick off recently. How do you think the negotiations will impact the performance of related stocks
Moo Earnings
Feb 17 19:21
Alibaba Q4 FY2024 Earnings Preview: Predict & Win Big! 🚀